Synthesis of new imidazole 3-oxides; unexpected deoxygenation of some derivatives in the reaction with 2,2,4,4-tetramethylcyclobutane-1,3-dithione

Article abstract of DOI:10.3987/COM-10-12130

Whereas the reaction of a series of 1,4,5-trisubstituted imidazole 3-oxides with 2,2,4,4-tetramethylcyclobutane-1,3-dithione gave the corresponding imidazole-2-thiones by a sulfur-transfer reaction via [2+3] cycloaddition, an unexpected deoxygenation occurred in the case of 4-acetyl-1-(adamantan-1-yl)- 5-methylimidazole 3-oxide. It was shown that the presence of an electronwithdrawing substituent at C(4) and the bulky 1-adamantyl group at N(1) are necessary to enable this reaction course. A reaction mechanism via a zwitterion, followed by a 1,3-cyclization and elimination of an oxathiirane, is proposed.

Full text of DOI:10.3987/COM-10-12130

HETEROCYCLES, Vol. 83, No. 4, 2011
765
HETEROCYCLES, Vol. 83, No. 4, 2011, pp. 765 - 776. © The Japan Institute of Heterocyclic Chemistry
Received, 28th December, 2010, Accepted, 21st February, 2011, Published online, 1st March, 2011
DOI: 10.3987/COM-10-12130
SYNTHESIS OF NEW IMIDAZOLE 3-OXIDES; UNEXPECTED
DEOXYGENATION OF SOME DERIVATIVES IN THE REACTION
WITH 2,2,4,4-TETRAMETHYLCYCLOBUTANE-1,3-DITHIONE
Grzegorz Mloston,a* Marcin Jasinski,a Dorota Rygielska,1,a and Heinz
Heimgartnerb*
a: University of !ód", Department of Organic and Applied Chemistry, Tamka 12,
PL-91-403 !ód", Poland: e-mail: gmloston@uni.lodz.pl
b: University of Zurich, Institute of Organic Chemistry, Winterthurerstrasse 190,
CH-8057 Zurich, Switzerland; e-mail: heimgart@oci.uzh.ch
Abstract – Whereas the reaction of a series of 1,4,5-trisubstituted imidazole
3-oxides with 2,2,4,4-tetramethylcyclobutane-1,3-dithione gave the corresponding
imidazole-2-thiones by a sulfur-transfer reaction via [2+3] cycloaddition, an
unexpected deoxygenation occurred in the case of 4-acetyl-1-(adamantan-1-yl)-
5-methylimidazole 3-oxide. It was shown that the presence of an electron-
withdrawing substituent at C(4) and the bulky 1-adamantyl group at N(1) are
necessary to enable this reaction course. A reaction mechanism via a zwitterion,
followed by a 1,3-cyclization and elimination of an oxathiirane, is proposed.
INTRODUCTION
Differently functionalized imidazole derivatives are useful building blocks for the preparation of
practically important compounds such as pharmaceuticals, agrochemicals, anti-corrosive agents, etc.2
Synthetic methods for the functionalization of the imidazole ring in the presence of a metal catalyst were
summarized in a recent review.3 The condensation of !-hydroxyimino ketones of type (1) with primary
amines and formaldehyde is widely applied for the synthesis of stable 2-unsubstituted imidazole 3-oxides
(2) (Scheme 1).4 These compounds are related in their structure with aldonitrones and display reactivities
analogous to this type of 1,3-dipoles. For example, they react easily with isocyanates, isothiocyanates,5
electron-deficient fluorinated olefins,6 and acetylene dicarboxylates4a,5 forming the corresponding
products (3–5) via initial [2+3] cycloaddition. The same mechanism is attributed to the formation of
imidazole-2-thiones (6) via the so-called sulfur-transfer reaction with 2,2,4,4-tetramethylcyclobutane-1,3-

766
HETEROCYCLES, Vol. 83, No. 4, 2011
dithione (7a).7 Similar to other heterocyclic N-oxides, compounds (2) can be deoxygenated, e.g. by
treatment with Raney-Ni.8
R2
O
OH
R2
R3
N
N
R1NH2 + CH2O +
R3
N
O
R1
1
2
S
S
CO2R
R4-N=C=O
7a
R2
R2
(CF3)2C=C(CN)2
N
NH
CO2R
NH
R2
R3
NHR4
R2
R3
S
N
N
O
NH
CN
R1
R1
CO2R
R3
R3
3
6
N
N
CO2R
CN
R1
R1
5
4
Scheme 1. Synthesis and selected transformations of imidazole 3-oxides
The goal of the present report was the synthesis of new imidazole 3-oxides bearing the
electron-withdrawing acetyl group at C(4) (2, R2 = MeCO) and the study of the reactivity of these
derivatives. In addition, some new imidazole 3-oxides bearing sterically crowded 1-adamantanyl residue
at N(1) should be obtained as potentially useful substrates for preparation of stable, nucleophilic
carbenes.9
RESULTS AND DISCUSSION
The preparation of 4-acetylimidazole 3-oxides 2a–d was carried out according to well established
protocols. In the case of 2a–c, the condensation of 3-(hydroxyimino)pentane-2,4-dione (8a) with the
corresponding 1,3,5-trisubstituted hexahydro-1,3,5-triazines (9a–c) occurred smoothly in ether at room
temperature (Scheme 2). The crystalline products precipitated directly from the reaction mixture. The
reaction of 8a with the monomeric N-methylidene adamantan-1-amine (10) was performed in acetic acid
at room temperature.10
In the first series of reactions, imidazole 3-oxides (2) were treated with dithione (7a) in order to obtain the
corresponding imidazole-2-thiones of type (6). The reactions with 2a–c occurred smoothly and led to the
desired thiones (6a–c) in good yields (Scheme 3). Unexpectedly, the analogous reaction with 2d afforded
1
a product, which in the H-NMR spectrum showed a singlet at 7.63 ppm, diagnostic for H–C(2) of an

HETEROCYCLES, Vol. 83, No. 4, 2011
767
imidazole derivative. After crystallization, a colorless product was isolated and identified by means of
spectroscopic methods as 4-acetyl-1-(adamantan-1-yl)-5-methylimidazole (11d).
Scheme 2. Preparation of 4-acetyl-5-methylimidazole 3-oxides (2a–d)
Scheme 3. Reaction of 4-acetyl-5-methylimidazole 3-oxides (2a–d) with 2,2,4,4-tetramethylcyclobutane-
1,3-dithione (7a)
The comparison of this result with those observed with 2a–c led us to the conclusion that the presence of
the bulky adamantyl residue is of key importance for the change of the reaction course. In order to check
the influence of substituents at C(4) and C(5) of the imidazole, two other model compounds 2e (R1 = Ad,
R2 = R3 = Me) and 2f (R1 = Ad, R2 = R3 = Ph) were prepared11 and used in the reaction with 7a. In both
cases, the corresponding imidazole-2-thiones (6e,f) were formed as major products. However, imidazoles
(11e,f) were also found (by 1H NMR) in the reaction mixtures as minor products (<10%).

768
HETEROCYCLES, Vol. 83, No. 4, 2011
A plausible explanation for the observed results is presented in Scheme 3. It seems likely that the
presence of the bulky adamantyl substituent at N(1) causes a stepwise mechanism leading to the
zwitterionic intermediate A. Due to the steric hindrance, the 1,5-cyclization (route a)), leading finally to
the sulfur transfer product (6) is disfavored and the competitive 1,3-cyclization (route b)) leads to the
oxathiirane derivative (12a) and the deoxygenated imidazole (11d). Electronic factors are also important:
the presence of an electron-withdrawing group at C(4) of the imidazole ring enhances the electrophilicity
of the oxygen atom in the intermediate zwitterion A, and therefore route b) may become more
advantageous in comparison with the alternative route a).
Oxathiiranes were postulated as unstable intermediates in some papers dealing with in situ generation of
thiocarbonyl S-sulfides in trapping experiments with aromatic thioketones.12 In search of additional proof
for the oxathiirane formation, a three-component reaction with 2d, 2,2,4,4-tetramethyl-3-
thioxocyclobutan-1-one (7b), and thiobenzophenone (13) was carried out. As expected, imidazole (11d)
was formed, but chromatographic workup also yielded a less polar fraction, in which the non-symmetrical
1,2,4-trithiolane (16) was identified as the major component and subsequently isolated by means of PLC
(Scheme 4).12 On the other hand, none of the two possible 1,2,4-trithiolanes with symmetrical
substitution pattern13,14 was found in the crude reaction mixtures based on the 1H-NMR analysis.
Scheme 4. Proposed reaction mechanism for the formation of 1,2,4-trithiolanes
In this transformation, the monothione (7b) is believed to act as a deoxygenating agent (see Scheme 3,
route b)), and the proposed oxathiirane (12b) transfers (S1) to either thiobenzophenone (13) or 7b.12a
Thiocarbonyl S-sulfides (thiosulfines) (14) and (15), respectively, appear as in situ generated
1,3-dipoles,13 which are trapped by thioketones (7b) and (13), respectively, as C=S dipolarophiles. In both
cases, the same 1,2,4-trithiolane (16)13 is formed as a stable product. Selective formation of the

HETEROCYCLES, Vol. 83, No. 4, 2011
769
‘non-symmetric’ 1,2,4-trithiolane (16) can be rationalized as follows: as evidenced in a series of papers
by Huisgen,15 aromatic thioketones are ‘superdipolarophilic’ and for that reason it seems very likely that
13 can be trapped by both thiosulfines (14) and (15) faster than the cycloaliphatic, sterically hindered
thioketone (7b). In addition, the ‘symmetrical’ 3,3,5,5-tetraphenyl-1,2,4-trithiolane undergoes easily the
thermal [2+3] cycloreversion.14 In contrast, ‘mixed’ 1,2,4-trithiolanes, such as 16, are thermally more
stable and do not undergo the [2+3] cycloreversion under the applied reaction conditions.13
Based on the presented observations, two other model N-oxides (2g) and (2h) with an adamantan-1-yl
group as a bulky substituent at N(1) and an electron-withdrawing group at C(4) (ester or amide function)
were prepared analogously to 2d and they were also tested in the reaction with dithioketone (7a). In both
cases, the reactions occurred smoothly and the obtained products were identified as the corresponding
deoxygenated imidazole derivatives (11g) and (11h), respectively (Scheme 5). An additional proof of the
structure 11g was obtained by deoxygenation of 2g with Raney-Ni.
Scheme 5. Deoxygenation of imidazole 3-oxides (2g,h)
CONCLUSIONS
The results presented showed that imidazole 3-oxides (2) bearing an electron-withdrawing substituent at
C(4) and the bulky 1-adamantyl residue at N(1) react with cycloaliphatic thiones (7a,b) via a stepwise
mechanism and, instead of imidazole-2-thiones (6), deoxygenated imidazoles (11) are formed. In fact,
[2+3] cycloaddition reactions of typical nitrones are common, and in the case of cycloaliphatic
thioketones, e.g. adamantanethione or 7b as dipolarophiles, stable 1,3,5-oxathiazolidines (and not the
regioisomeric 1,2,5-oxathiazolidines!) were isolated in high yields.16 Reactions of nitrones with aromatic
thioketones, e.g. 13, occur with the same regioselectivity, i.e. with carbophilic attack of the oxygen atom
onto the C=S bond.15c,17 The switch from the concerted to the non-concerted [2+3] cycloaddition requires
steric hindrance in the 1,3-dipole or the dipolarophile.18a In addition, electronic effects, leading to
stabilization of the resulting zwitterions, play also an important role.18 Apparently, both factors influence
the course of the [2+3] cycloaddition of the ‘nitrone-like’ imidazole N-oxides 2d,g,h, and finally lead to a
stepwise course of their reactions with cycloaliphatic thioketones 7a and 7b. The three-component

770
HETEROCYCLES, Vol. 83, No. 4, 2011
reaction with 2d, 7b and thiobenzophenone (13) evidenced the intermediacy of an oxathiirane derivative19
acting as a (S1)-transferring reagent.
EXPERIMENTAL
General remarks. Melting points were determined in capillaries using a MEL-TEMP II apparatus
(Aldrich) and are uncorrected. The IR spectra were recorded with a FT-IR NEXUS spectrophotometer as
1
13
KBr pellets or as films, and the absorptions (") are given in cm-1. H-NMR and C-NMR spectra were
recorded on a BRUKER AVANCE III instrument (1H at 600 and C at 150 MHz) in CDCl3 solutions;
13
chemical shifts (#) in ppm; coupling constants (J) in Hz. The multiplicity of the 13C signals was deduced
1
from DEPT spectra, supported by H-13C HMQC spectra. The mass spectra were recorded on a Finnigan
MAT-95 instrument using electrospray ionization (ESI); m/z (rel. %).
Starting materials. Used reagents such as alkylamines, carbonyl compounds, inorganic reagents, and
solvents are commercially available and were used as received. !-(Hydroxyimino)ketones were obtained
according to known protocols as follows: 3-(hydroxyimino)pentane-2,4-dione20a (8a) and ethyl
2-hydroxyimino-3-oxobutanoate20b (8b) were prepared from acetoacetate and ethyl acetoacetate,
respectively, by treatment with NaNO2 in glacial AcOH; 2-hydroxyimino-3-oxo-N-phenylbutyramide20c
(8c) was synthesized in a two step procedure by acetoacetylation of aniline and subsequent nitrosylation.
The 2,2,4,4-tetramethylcyclobutane-1,3-dithione (7a), and 2,2,4,4-tetramethyl-3-thioxocyclobutanone
(7b) were obtained by thionation of 2,2,4,4-tetramethylcyclobutane-1,3-dione with P4S10.21 The synthesis
of 1-(adamantan-1-yl)-4,5-dimethyl-1H-imidazole 3-oxide (2e) and 1-(adamantan-1-yl)-4,5-diphenyl-
1H-imidazole 3-oxide (2f) was previously described.11
Synthesis of 4-acetylimidazole 3-oxides (2a–c). – General procedure. To a magnetically stirred
solution of a 1,3,5-trisubstituted hexahydro-1,3,5-triazine (9a–c, 12 mmol) in Et2O (20 mL), a solution of
3-(hydroxyimino)pentane-2,4-dione (8a, 10 mmol, 1.3 g) in Et2O (10 mL) was added portionwise at 0 °C.
After stirring for 20 h at rt, the solvent was removed under reduced pressure. The crude product (2a, 2b)
was triturated with Et2O (4 $ ca. 20 mL), cooled (in the fridge, 16 h), filtered, and purified by
recrystallization. In the case of 2c, the crude product obtained as yellow oil was purified
chromatographically (SiO2 column).
4-Acetyl-1,5-dimethyl-1H-imidazole 3-oxide (2a). Yield: 1.36 g (91%). Colorless crystals, mp
136–138 °C (CHCl3). IR (KBr): 3277vs (br.), 3106s, 1673vs (C=O), 1564s, 1404s, 1376m, 1365m, 1338m,
1
1262s, 1212m, 1030m, 960m. H-NMR (CDCl3): 7.77 (s, 1H, HC(2)); 3.57 (s, 3H, MeN); 2.83 (s, 3H,

HETEROCYCLES, Vol. 83, No. 4, 2011
771
13
MeCO); 2.51 (s, 3H, Me). C-NMR (CDCl3): 191.3 (s, C=O); 132.2, 126.0 (2s, C(4), C(5)); 129.5 (d,
C(2)); 32.0, 30.6, 9.9 (3q, 3 Me). ESI-HRMS: 177.0633 (calcd. 177.0634 for C7H10N2NaO2, [M+Na]+),
155.0816 (calcd. 155.0815 for C7H11N2O2, [M+1]+).
4-Acetyl-1-cyclohexyl-5-methyl-1H-imidazole 3-oxide (2b). Yield: 1.31 g (59%). Colorless crystals, mp
147–148 °C (CHCl3/Et2O). IR (KBr): 3067s, 2945vs, 2928vs, 2856s, 1667vs (C=O), 1566vs, 1450m,
1
1423s, 1366m, 1326s, 1254s, 1234m, 1123m, 1040m. H-NMR (CDCl3): 7.82 (s, 1H, HC(2)); 3.92–2.88
(m, 1H, cHex); 2.84, 2.52 (2s, 6H, 2 Me); 2.04–1.95 (m, 4H, cHex); 1.80–1.78 (m, 1H, cHex); 1.57–1.39
13
(m, 4H, cHex); 1.29–1.19 (m, 1H, cHex). C-NMR (CDCl3): 191.6 (s, C=O); 130.9, 123.2 (2s, C(4),
C(5)); 129.1 (d, C(2)); 55.3 (d, CH, cHex); 33.4, 25.3, 24.7 (3d, 5CH2, cHex); 30.6, 11.2 (2q, 2 Me).
ESI-HRMS: 245.1257 (calcd. 245.1260 for C12H18N2NaO2, [M+Na]+), 223.1440 (calcd. 223.1441 for
C12H19N2O2, [M+1]+).
4-Acetyl-1-benzyl-5-methyl-1H-imidazole 3-oxide (2c). Yield after CC (SiO2, AcOEt, then AcOEt/MeOH
1:1): 1.31 g (57%). Pale yellow semi-solid. IR (KBr): 3061m, 2990m, 2958m, 2926m, 1663vs (C=O),
1
1563s, 1468m, 1457m, 1425m, 1406m, 1376m, 1366m, 1330m, 1268m, 1227m, 1125m, 702s. H-NMR
(CDCl3): 7.86 (s, 1H, HC(2)); 7.35–7.31 (m, 3 arom. H); 7.09–7.08 (m, 2 arom. H); 5.00 (s, 2H, CH2);
2.77 (s, 3H, MeCO); 2.41 (s, 3H, Me). 13C-NMR (CDCl3): 191.3 (s, C=O); 133.1, 132.0, 125.9 (3s, C(Ph),
C(4), C(5)); 129.7 (d, C(2)); 129.3, 128.9, 127.0 (3d, 5 arom. CH); 49.2 (t, CH2); 30.6, 10.1 (2q, 2 Me).
ESI-HRMS: 253.09479 (calcd. 253.09475 for C13H14N2NaO2, [M+Na]+), 231.11294 (calcd. 231.11280 for
C13H15N2O2, [M+1]+).
Synthesis of 1-(adamantan-1-yl)-5-methyl-1H-imidazole 3-oxides (2d, 2g and 2h). – General
procedure. A solution of N-methylidene adamantan-1-amine (10, 12.0 mmol, 1.96 g) and a
corresponding !-(hydroxyimino)ketone (8a-c, 10.0 mmol) in glacial AcOH (40 mL) was stirred for 24 h
at rt. The resulting mixture was filtered, gaseous HCl was bubbled through the filtrate for 1.5 h at rt, and
the solvent removed under reduced pressure. The crude hydrochloride was triturated with Et2O (3 $ 20
mL), and the solid material was dissolved in CHCl3/MeOH (4:1, 30 mL). The resulting solution was
treated with excess solid NaHCO3, stirred for 2 h, and filtered. Then, solvents were removed in vacuo.
4-Acetyl-1-(adamantan-1-yl)-5-methyl-1H-imidazole 3-oxide (2d). The crude product was washed with
Et2O and used in the next step without further purification (attempted recrystallization from CHCl3 led to
the isomeric imidazole-2-one). Yield: 0.90 g (33%). Colorless solid, mp 170–172 °C. IR (KBr): 2915vs,
1
2855m, 1672vs (C=O), 1636m, 1552vs, 1457m, 1405m, 1363m, 1248s, 1134m, 1091m. H-NMR

772
HETEROCYCLES, Vol. 83, No. 4, 2011
(CDCl3): 7.91 (s, 1H, HC(2)); 2.80, 2.69 (2s, 6H, 2 Me); 2.20-2.28 (m, 3H, Ad); 2.14-2.20 (m, 6H, Ad);
1.76, 1.71 (AB-like, J = 12.7, 6H, Ad). 13C-NMR (CDCl3): 191.7 (s, C=O); 131.8, 125.0 (2s, C(4), C(5));
129.6 (d, C(2)); 61.0 (s, C(Ad)); 41.6 (t, 3 CH2(Ad)), 35.3 (d, 3 CH(Ad)); 29.5 (t, 3 CH2(Ad)); 28.9, 13.5
(2q, 2 Me). ESI-HRMS: 297.15692 (calcd. 297.15735 for C16H22N2NaO2, [M+Na]+), 275.17507 (calcd.
275.117540 for C16H23N2O2, [M+1]+).
N-Phenyl-1-(adamantan-1-yl)-5-methyl-3-oxido-1H-imidazole-4-carboxamide (2g). The crude product
was purified by flash chromatography (SiO2, CHCl3/MeOH 95:5, Rf = 0.50) and recrystallized. Yield:
1.65 g (47%). Colorless crystals, mp 228-231 °C (decomp.) (CH2Cl2/Et2O). IR (KBr): 2923s, 2906s,
2858m, 2848m, 1671s (br., C=O), 1621s, 1599vs, 1581s, 1566s, 1498m, 1447m, 1407m, 1302s, 1138m,
761m. 1H-NMR (CDCl3): 13.17 (br.s, 1H, NH); 8.04 (s, 1H, HC(2)); 7.71–7.69 (m, 2 arom. H); 7.33–7.30
(m, 2 arom. H); 7.09–7.06 (m, 1 arom. H); 2.94 (s, 3H, Me); 2.25-2.30 (m, 3H, Ad); 2.17-2.21, 2.23-2.27
13
(2m, 6H, Ad); 1.79, 1.74 (AB-like, J = 12.7, 6H, Ad). C-NMR (CDCl3): 158.0 (s, C=O); 138.2, 131.5,
122.6 (3s, C(Ph), C(4), C(5)); 128.8, 123.9, 123.6, 120.6 (4d, 5 arom. CH, C(2)); 60.9 (s, C(Ad)); 41.9 (t,
CH2(Ad)), 35.5 (d, CH(Ad)); 29.6 (t, CH2(Ad)); 13.3 (q, Me). ESI-HRMS: 374.18377 (calcd. 374.18390
for C21H25N3NaO2, [M+Na]+), 352.20187 (calcd. 352.20195 for C21H26N3O2, [M+1]+).
Ethyl 1-(adamantan-1-yl)-5-methyl-3-oxido-1H-imidazole-4-carboxylate (2h). Yield after CC (SiO2,
AcOEt/MeOH 1:1): 1.03 g (34%). Colorless crystals, mp 185-187 °C (capillary must be placed into
apparatus, preheated to ca. 180 °C) (CH2Cl2/Et2O). IR (KBr): 2974m, 2912s (br.), 2859m, 1693vs (C=O),
1581m, 1412m, 1276s, 1258s, 1141m, 1119m. 1H-NMR (CDCl3): 8.04 (s, 1H, HC(2)); 4.42 (q, J = 7.1, 2H,
MeCH2O); 2.70 (s, 3H, Me); 2.25-2.29 (m, 3H, Ad); 2.12-2.16, 2.20-2.24 (2m,, 6H, Ad); 1.78, 1.73
13
(AB-like, J = 12.6, 6H, Ad); 1.40 (t, J = 7.1, 3H, MeCH2O). C-NMR (CDCl3): 159.7 (s, C=O); 131.6,
123.6 (2s, C(4), C(5)); 124.9 (d, C(2)); 61.2 (t, MeCH2O); 60.8 (s, C(Ad)); 41.9 (t, 3 CH2(Ad)), 35.5 (d, 3
CH(Ad)); 29.6 (t, 3 CH2(Ad)); 14.3 (q, MeCH2O); 13.5 (q, Me). ESI-HRMS: 327.16779 (calcd.
327.16791 for C17H24N2NaO3, [M+Na]+), 305.18596 (calcd. 305.18597 for C17H25N2O3, [M+1]+).
Reactions of imidazole 3-oxides (2a–c,e,f) with 2,2,4,4-tetramethylcyclobuta-1,3-dithione (7a) leading to
the corresponding imidazole-2-thiones (6). – General procedure. To the solution of an imidazole 3-oxide
(2, 1.0 mmol) in CHCl3 (5.0 mL), the solution of 7a (103 mg, 0.6 mmol) in CHCl3 (3.0 mL) was added
dropwise at 0 °C, and the mixture was stirred overnight at rt. After evaporation of the solvent under
reduced pressure, the crude products were washed with hexane, filtered, and purified by recrystallization
from appropriate solvents.

HETEROCYCLES, Vol. 83, No. 4, 2011
773
4-Acetyl-1,5-dimethylimidazole-2(3H)-thione (6a). Yield: 117 mg (69%). Colorless crystals, mp
241-243 °C (EtOH). IR (KBr): 3100–2900vs (br.), 1652vs (C=O), 1600m, 1490m, 1431m, 1407m, 1386m,
1
1370m, 1344m. H-NMR (CDCl3): 10.40 (br.s, 1H, NH); 3.60 (s, 3H, MeN); 2.52, 2.46 (2s, 6H, 2 Me).
13C-NMR (CDCl3): 185.3 (s, C=O); 163.5 (s, C=S); 133.9, 124.3 (2s, C(4), C(5)); 31.4, 28.2, 11.4 (3q, 3
Me). ESI-HRMS: 193.0407 (calcd. 193.0406 for C7H10N2NaOS, [M+Na]+), 171.0587 (calcd. 171.0587 for
C7H11N2OS, [M+1]+).
4-Acetyl-1-cyclohexyl-5-methylimidazole-2(3H)-thione (6b). Yield: 140 mg (59%). Colorless needles, mp
215–217 °C (EtOH). IR (KBr): 3114vs, 2934vs, 2851s, 1670vs (C=O), 1588m, 1497s, 1414s, 1368m,
1
1327m, 1257m, 1230m, 1158m, 1143m, 951m. H-NMR (CDCl3): 10.96 (br.s, 1H, NH); 5.24 (m, 1H,
cHex); 2.64, 2.47 (2s, 6H, 2 Me); 1.93-1.21 (m, 10H, cHex). 13C-NMR (CDCl3): 186.2 (s, C=O); 162.6 (s,
C=S); 134.3, 124.5 (2s, C(4), C(5)); 57.9 (d, CH, cHex); 28.7, 26.1, 25.2 (3d, 5CH2, cHex); 30.3, 12.3 (2q,
2 Me). ESI-HRMS: 261.1032 (calcd. 261.1032 for C12H18N2NaOS, [M+Na]+), 239.1210 (calcd. 239.1213
for C12H19N2OS, [M+1]+).
4-Acetyl-1-benzyl-5-methylimidazole-2(3H)-thione (6c). Yield 177 mg (72%). Colorless solid, mp
225–226 °C (CHCl3/Et2O). IR (KBr): 3116s (br.), 3080m, 2962m, 1667vs (C=O); 1598s, 1504s, 1413s,
1
1372m, 1348m, 1272m, 731m. H-NMR (CDCl3): 10.29 (br.s, 1H, NH); 7.35–7.33 (m, 2 arom. H);
13
7.31–7.26 (m, 3 arom. H); 5.40 (s, 2H, CH2); 2.43, 2.38 (2s, 6H, 2 Me). C-NMR (DMSO-d6): 188.4 (s,
C=O); 164.6 (s, C=S); 137.2, 135.9, 125.4 (3s, C(Ph), C(4), C(5)); 47.8 (t, CH2); 29.6, 12.2 (2q, 2 Me).
ESI-HRMS: 269.07207 (calcd. 269.07190 for C13H14N2NaOS, [M+Na]+), 247.08994 (calcd. 247.08996
for C13H15N2OS, [M+1]+).
1-(Adamantan-1-yl)-4,5-dimethylimidazole-2(3H)-thione (6e). Yield: 185 mg (71%). Colorless solid, mp
320–322 °C (CHCl3). IR (KBr): 3158m, 3093m, 2916s, 2891m, 2855m, 1648m, 1501m, 1443m, 1366m,
1327m, 1309m, 1222s. 1H-NMR (CDCl3): 9.65 (br.s, 1H, NH); 2.72-2.76, 2.80-2.84 (2m, 6H, Ad); 2.23 (s,
13
3H, Me); 2.18-2.22 (m, 3H, Ad); 2.01 (s, 3H, Me); 1.81, 1.69 (AB-like, J = 11.4, 6H, Ad). C-NMR
(CDCl3): 159.2 (s, C=S); 122.9, 120.6 (2s, C(4), C(5)); 64.3 (s, C(Ad)); 40.5 (t, 3 CH2(Ad)), 36.0 (d, 3
CH(Ad)), 30.3 (t, 3 CH2(Ad)), 14.9, 9.5 (2q, 2 Me). ESI-HRMS: 285.13946 (calcd. 285.13959 for
C15H22N2NaS, [M+Na]+), 263.15760 (calcd. 263.15765 for C15H23N2S, [M+1]+).
1-(Adamantan-1-yl)-4,5-diphenylimidazole-2(3H)-thione (6f). Yield: 247 mg (64%). Colorless solid, mp
284–285 °C (CHCl3). IR (KBr): 3054m, 2909vs, 2851m, 1495m, 1445m, 1370m, 1326m, 1225m.
1H-NMR (CDCl3): 9.44 (br.s, 1H, NH); 7.41–7.31 (m, 5 arom. H); 7.17–7.14 (m, 3 arom. H); 6.91–6.89

774
HETEROCYCLES, Vol. 83, No. 4, 2011
(m, 2 arom. H); 2.23-2.57, 2.61-2.65 (2m, 6H, Ad); 2.02-2.06 (m, 3H, Ad); 1.67, 1.57 (AB-like, J = 11.4,
13
6H, Ad). C-NMR (CDCl3): 161.1 (s, C=S); 133.0, 128.2, 128.1, 126.0 (4s, 2 C(Ph), C(4), C(5)); 132.4,
129.1, 128.5, 128.4, 127.8, 126.7 (6d, 10 arom. CH); 65.6 (s, C(Ad)); 41.1 (t, 3 CH2(Ad)); 35.8 (d, 3
CH(Ad)); 30.4 (t, 3 CH2(Ad)). ESI-HRMS: 409.17050 (calcd. 409.17089 for C25H26N2NaS, [M+Na]+),
387.18886 (calcd. 387.18895 for C25H27N2S, [M+1]+).
Reactions of imidazole 3-oxides (2d,g,h) with 2,2,4,4-tetramethylcyclobuta-1,3-dithione (7a) leading to
the corresponding imidazoles (11). – General procedure. To the solution of imidazole 3-oxide (1.0 mmol)
in CHCl3 (5.0 mL), the solution of 7a (309 mg, 1.8 mmol) in CHCl3 (3.0 mL) was added dropwise at 0 °C,
and the mixture was stirred at rt until the starting N-oxide was completely consumed (usually ca. 30 min,
TLC monitoring: SiO2, AcOEt/MeOH 1:1; in the case of 2h, stirring was continued overnight). After
evaporation of the solvent under reduced pressure, the crude products were washed with hexane, filtered,
and purified by recrystallization from appropriate solvents.
4-Acetyl-1-(adamantan-1-yl)-5-methylimidazole (11d). Yield: 165 mg (64%). Colorless needles, mp
185–187 °C (MeOH/CH2Cl2). IR (KBr): 2920s, 2857m, 1667vs (C=O), 1538s, 1373m, 1265m, 1227m,
1146m, 921m. 1H-NMR (CDCl3): 7.53 (s, 1H, HC(2)); 2.80, 2.54 (2s, 6H, 2 Me); 2.21-2.27 (m, 3H, Ad);
2.20-2.26 (m, 6H, Ad); 1.78, 1.74 (AB-like, J = 12.5, 6H, Ad). 13C-NMR (CDCl3): 196.7 (s, C=O); 138.7,
134.3 (2s, C(4), C(5)); 133.2 (d, C(2)); 58.3 (s, C(Ad)); 42.0 (t, 3 CH2(Ad)); 35.7 (d, 3 CH(Ad)); 29.5 (t,
3 CH2(Ad)); 27.7, 13.7 (2q, 2 Me). ESI-HRMS: 281.16218 (calcd. 281.16243 for C16H22N2NaO,
[M+Na]+), 259.18048 (calcd. 259.18049 for C16H23N2O, [M+1]+).
N-Phenyl-1-(adamantan-1-yl)-5-methylimidazole-4-carboxamide (11g). Yield 291 mg (87%). Colorless
crystals, mp 189–191 °C (CH2Cl2/MeOH). IR (KBr): 3360m, 2911vs (br.), 2853m, 1671s, 1593s, 1569s,
1
1522s, 1498s, 1438s, 1310m, 1242m, 1149m, 750m, 692m. H-NMR (CDCl3): 9.16 (br.s, 1H, NH);
7.69–7.67 (m, 2 arom. H); 7.54 (s, 1H, HC(2)); 7.34–7.31 (m, 2 arom. H); 7.08–7.06 (m, 1 arom. H); 2.92
(s, 3H, Me); 2.24-2.30 (m, 3H, Ad); 2.23-2.29 (m, 6H, Ad); 1.80, 1.76 (AB-like, J = 12.6, 6H, Ad).
13C-NMR (CDCl3): 162.2 (s, C=O); 138.5, 133.4, 132.7 (3s, C(Ph), C(4), C(5)); 132.6 (d, C(2)); 128.8,
123.4, 119.5 (3d, 5 arom. CH); 58.5 (s, C(Ad)); 42.1 (t, 3 CH2(Ad)), 35.8 (d, 3 CH(Ad)); 29.6 (t, 3
CH2(Ad)); 13.3 (q, Me). ESI-HRMS: 358.18877 (calcd. 358.18898 for C21H25N3NaO, [M+Na]+),
336.20666 (calcd. 336.20704 for C21H26N3O, [M+1]+).
Ethyl 1-(adamantan-1-yl)-5-methylimidazole-4-carboxylate (11h). Yield 153 mg (53%). Colorless solid,
mp 188–189 °C (CH2Cl2/hexane). IR (KBr): 2919vs, 2855m, 1697vs (C=O), 1554m, 1378m, 1368m,

HETEROCYCLES, Vol. 83, No. 4, 2011
775
1
1338m, 1306m, 1231s, 1204m, 1185s, 1153m, 1101m, 1075m. H-NMR (CDCl3): 7.61 (s, 1H, HC(2));
4.35 (q, J = 7.0, 2H, MeCH2O); 2.81 (s, 3H, Me); 2.24-2.28 (m, 3H, Ad); 2.22-2.27 (m, 6H, Ad); 1.79,
13
1.76 (AB-like, J = 12.6, 6H, Ad); 1.39 (t, J = 7.0, 3H, MeCH2O). C-NMR (CDCl3): 164.2 (s, C=O);
135.7, 130.9 (2s, C(4), C(5)); 134.1 (d, C(2)); 60.0 (s, C(Ad)); 58.4 (t, MeCH2O); 42.1 (t, 3 CH2(Ad)),
35.8 (d, 3 CH(Ad)); 29.6 (t, 3 CH2(Ad)); 14.5 (q, MeCH2O); 13.3 (q, Me). ESI-HRMS: 289.19096 (calcd.
289.19105 for C17H25N2O2, [M+1]+).
Deoxygenation of 2h with Raney-nickel. To a magnetically stirred mixture of imidazole 3-oxide (2g,
281 mg, 0.80 mmol) in EtOH (45.0 mL), a suspension of freshly prepared Raney-nickel in EtOH was
added in small portions at rt and stirring was continued until the starting material was completely
consumed (TLC). The crude mixture was filtered through Celite, washed with several portions of CHCl3,
the solvents of the filtrate were evaporated. The resulting residue was purified by preparative TLC (SiO2,
CHCl3/MeOH 95:5, Rf = 0.88) to give 201 mg (75%) of 11g as colorless solid. The isolated material was
identical with that obtained in the reaction of 2g with 7a.
Three-component (trapping) experiment. To the mixture of 7b (312 mg, 2.0 mmol) and
thiobenzophenone (198 mg, 1.0 mmol) in CHCl3 (1.0 mL), a solution of imidazole 3-oxide (2d, 274 mg,
1.0 mmol) in CHCl3 (2.0 mL) was added dropwise at 0 °C and the mixture stirred for 3 h at rt. Then, the
solvent was removed, the resulting mixture was treated with Et2O, and the colorless precipitate of crude
11d (172 mg, 67%) was filtered off. The solvent of the filtrate was evaporated, the resulting mixture was
separated by PLC (SiO2) using CH2Cl2/petroleum ether 3:7 as the solvent to give 1,2,4-trithiolane (16, Rf
1
= 0.75, 45 mg, 12%) as colorless solid. H-NMR (CDCl3): 7.62–7.60 (m, 4 arom. H); 7.31–7.28 (m, 6
arom. H); 1.51 (s, 6H, 2 Me); 1.42 (s, 6H, 2 Me).
ACKNOWLEDGEMENTS
The authors thank PD Dr. L. Bigler, University of Zürich, for ESI-HRMS. Financial support by the
Rector of the University of Lodz (Grant # 505/712/R) and technical assistance in the laboratory work by
Mrs Ma#gorzata Celeda, University of Lodz, are gratefully acknowledged.
REFERENCES (AND NOTES)
1.
2.
Part of the Master Thesis of D. R., University of Lodz, 2010.
N. X. Huang and L. Liu, 'Compr. Heterocycl. Chem. III', Vol. 4, Chapter 4.02, ed. by A. R.
Katritzky, C. A. Ramsden, E. F. V. Scriven, and R. J. K. Taylor, Pergamon Press, Oxford UK, 2008,
pp. 143–364.

776
HETEROCYCLES, Vol. 83, No. 4, 2011
3.
4.
F. Bellina and R. Rossi, Adv. Synth. Catal., 2010, 352, 1223.
a) I. J. Ferguson and K. Schofield, J. Chem. Soc., Perkin Trans. 1, 1975, 275; b) R. Bartnik, W. E.
Hahn, and G. Mloston, Rocz. Chem., 1977, 51, 49.
5.
6.
G. Mloston, T. Gendek, and H. Heimgartner, Tetrahedron, 2000, 56, 5405.
a) G. Mloston, M. Jasinski, A. Linden, and H. Heimgartner, Helv. Chim. Acta, 2006, 89, 1304; b) R.
Loska and M. Makosza, Mendeleev Commun., 2006, 161; c) R. Loska and M. Makosza, Chem. Eur.
J., 2008, 14, 2577.
7.
8.
G. Mloston, T. Gendek, and H. Heimgartner, Helv. Chim. Acta, 1998, 81, 1585.
a) M. Jasinski, G. Mloston, P. Mucha, A. Linden, and H. Heimgartner, Helv. Chim. Acta, 2007, 90,
1765; b) P. Mucha, G. Mloston, M. Jasinski, A. Linden, and H. Heimgartner, Tetrahedron:
Asymmetry, 2008, 19, 1600.
9.
a) W. A. Herrmann, Angew. Chem. Int. Ed., 2002, 41, 1290; b) D. Bourissou, O. Guerret, F. P.
Gabbaï, and G. Bertrand, Chem. Rev., 2000, 100, 39.
10. M. Jasinski, G. Mloston, A. Linden, and H. Heimgartner, Helv. Chim. Acta, 2008, 91, 1916.
11. G. Mloston and M. Jasinski, ARKIVOC, 2011, (vi), 162.
12. a) R. Huisgen, G. Mloston, K. Polborn, and F. Palacios-Gambra, Liebigs Ann./Rec., 1997, 187; b)
W. Adam, R. M. Bargon, and G. Mloston, Eur. J. Org. Chem., 2003, 4012.
13. G. Mloston and H. Heimgartner, Helv. Chim. Acta, 1995, 78, 1298.
14. R. Huisgen and J. Rapp, Tetrahedron, 1997, 53, 939.
15. a) R. Huisgen and E. Langhals, Tetrahedron Lett., 1989, 30, 5369; b) R. Huisgen and E. Langhals,
Heteroatom Chem., 2006, 17, 433; c) R. Huisgen, L. Fisera, H. Giera, and R. Sustmann, J. Am.
Chem. Soc., 1995, 117, 9671.
16. a) D. S. C. Black and K. G. Watson, Aust. J. Chem., 1973, 26, 2491; b) see also in a review: D. S. C.
Black, R. F. Crozier, and V. Ch. Davis, Synthesis, 1975, 205.
17. R. Sustmann, W. Sicking, and R. Huisgen, J. Am. Chem. Soc., 1995, 117, 9679.
18. a) H. Giera, R. Huisgen, E. Langhals, and K. Polborn, Helv. Chim. Acta, 2002, 85, 1523; b) G.
Mloston, R. Huisgen, H. Giera, and E. Langhals, Tetrahedron, 2002, 58, 507.
19. P. R. Schreiner, H. P. Reisenauer, J. Romanski, and G. Mloston, J. Am. Chem. Soc., 2010, 132,
7240.
20. a) X.-H. Cai, H.-J. Yang, and G.-L. Zhang, Synthesis, 2005, 10, 1569; b) I. R. Corrêa Jr. and P. J. S.
Moran, Tetrahedron, 1999, 55, 14221; c) G. Mloston and M. Jasinski, Collect. Czech. Chem.
Commun., 2010, 75, 871.
21. E. V. Elam and H. W. Davis, J. Org. Chem., 1967, 32, 1562.